Charles Schwab Investment Management Inc Altimmune, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Altimmune, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 142,705 shares of ALT stock, worth $948,988. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,705
Previous 142,705
-0.0%
Holding current value
$948,988
Previous $1.61 Million
9.53%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ALT
# of Institutions
185Shares Held
44.4MCall Options Held
1.1MPut Options Held
647K-
State Street Corp Boston, MA8.65MShares$57.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.04MShares$26.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$20.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$18.3 Million3.41% of portfolio
-
Morgan Stanley New York, NY2.21MShares$14.7 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $326M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...